Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 346.29 Million USD | -33.53% |
| 2022 | 520.98 Million USD | 85.87% |
| 2021 | 280.29 Million USD | 111.17% |
| 2020 | 132.73 Million USD | 16.7% |
| 2019 | 113.73 Million USD | 16.49% |
| 2018 | 97.63 Million USD | -12.23% |
| 2017 | 111.23 Million USD | 21.1% |
| 2016 | 91.85 Million USD | 18.49% |
| 2015 | 77.51 Million USD | -28.83% |
| 2014 | 108.91 Million USD | 0.22% |
| 2013 | 108.66 Million USD | -3.66% |
| 2012 | 112.79 Million USD | 1.29% |
| 2011 | 111.35 Million USD | -0.4% |
| 2010 | 111.8 Million USD | -7.87% |
| 2009 | 121.35 Million USD | -11.73% |
| 2008 | 137.47 Million USD | -0.85% |
| 2007 | 138.65 Million USD | 3.57% |
| 2006 | 133.87 Million USD | 19.58% |
| 2005 | 111.95 Million USD | 38.99% |
| 2004 | 80.54 Million USD | 232.87% |
| 2003 | 24.19 Million USD | 56.87% |
| 2002 | 15.42 Million USD | 23.66% |
| 2001 | 12.47 Million USD | 77.25% |
| 2000 | 7.03 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 311.99 Million USD | -9.9% |
| 2024 Q2 | 276.29 Million USD | -11.44% |
| 2023 Q4 | 346.29 Million USD | -14.84% |
| 2023 Q3 | 406.63 Million USD | -12.33% |
| 2023 Q2 | 463.83 Million USD | -7.2% |
| 2023 Q1 | 499.79 Million USD | -4.07% |
| 2023 FY | 346.29 Million USD | -33.53% |
| 2022 Q1 | 266.69 Million USD | -4.85% |
| 2022 Q2 | 424.09 Million USD | 59.02% |
| 2022 Q3 | 428.15 Million USD | 0.96% |
| 2022 Q4 | 520.98 Million USD | 21.68% |
| 2022 FY | 520.98 Million USD | 85.87% |
| 2021 Q3 | 268.44 Million USD | 1.62% |
| 2021 FY | 280.29 Million USD | 111.17% |
| 2021 Q4 | 280.29 Million USD | 4.41% |
| 2021 Q1 | 259.73 Million USD | 95.68% |
| 2021 Q2 | 264.16 Million USD | 1.71% |
| 2020 Q2 | 113.41 Million USD | 20.11% |
| 2020 Q4 | 132.73 Million USD | 7.54% |
| 2020 Q1 | 94.43 Million USD | -16.98% |
| 2020 FY | 132.73 Million USD | 16.7% |
| 2020 Q3 | 123.42 Million USD | 8.83% |
| 2019 Q4 | 113.73 Million USD | 2.25% |
| 2019 Q3 | 111.23 Million USD | 3.05% |
| 2019 Q2 | 107.94 Million USD | 10.88% |
| 2019 Q1 | 97.35 Million USD | -0.29% |
| 2019 FY | 113.73 Million USD | 16.49% |
| 2018 Q1 | 108.12 Million USD | -2.8% |
| 2018 Q3 | 118.93 Million USD | 2.77% |
| 2018 Q4 | 97.63 Million USD | -17.91% |
| 2018 FY | 97.63 Million USD | -12.23% |
| 2018 Q2 | 115.73 Million USD | 7.03% |
| 2017 Q2 | 95.15 Million USD | 7.77% |
| 2017 Q4 | 111.23 Million USD | 10.52% |
| 2017 FY | 111.23 Million USD | 21.1% |
| 2017 Q1 | 88.29 Million USD | -3.88% |
| 2017 Q3 | 100.64 Million USD | 5.78% |
| 2016 Q2 | 75.63 Million USD | 1.26% |
| 2016 FY | 91.85 Million USD | 18.49% |
| 2016 Q4 | 91.85 Million USD | 13.43% |
| 2016 Q3 | 80.97 Million USD | 7.07% |
| 2016 Q1 | 74.69 Million USD | -3.64% |
| 2015 FY | 77.51 Million USD | -28.83% |
| 2015 Q1 | 104.02 Million USD | -4.49% |
| 2015 Q2 | 94.24 Million USD | -9.4% |
| 2015 Q3 | 75.91 Million USD | -19.45% |
| 2015 Q4 | 77.51 Million USD | 2.11% |
| 2014 Q2 | 105.68 Million USD | -1.56% |
| 2014 FY | 108.91 Million USD | 0.22% |
| 2014 Q4 | 108.91 Million USD | 1.86% |
| 2014 Q3 | 106.92 Million USD | 1.17% |
| 2014 Q1 | 107.36 Million USD | -1.2% |
| 2013 FY | 108.66 Million USD | -3.66% |
| 2013 Q1 | 113.47 Million USD | 0.6% |
| 2013 Q3 | 107.51 Million USD | -6.43% |
| 2013 Q2 | 114.9 Million USD | 1.26% |
| 2013 Q4 | 108.66 Million USD | 1.08% |
| 2012 Q1 | 107.96 Million USD | -3.04% |
| 2012 Q3 | 109.08 Million USD | 0.71% |
| 2012 FY | 112.79 Million USD | 1.29% |
| 2012 Q2 | 108.31 Million USD | 0.32% |
| 2012 Q4 | 112.79 Million USD | 3.4% |
| 2011 Q3 | 108.96 Million USD | -1.15% |
| 2011 Q4 | 111.35 Million USD | 2.19% |
| 2011 FY | 111.35 Million USD | -0.4% |
| 2011 Q1 | 109.44 Million USD | -2.11% |
| 2011 Q2 | 110.23 Million USD | 0.71% |
| 2010 FY | 111.8 Million USD | -7.87% |
| 2010 Q3 | 112.17 Million USD | -2.16% |
| 2010 Q4 | 111.8 Million USD | -0.33% |
| 2010 Q2 | 114.65 Million USD | -3.56% |
| 2010 Q1 | 118.88 Million USD | -2.03% |
| 2009 Q3 | 119.43 Million USD | -10.78% |
| 2009 Q4 | 121.35 Million USD | 1.6% |
| 2009 Q1 | 134.67 Million USD | -2.04% |
| 2009 Q2 | 133.86 Million USD | -0.6% |
| 2009 FY | 121.35 Million USD | -11.73% |
| 2008 FY | 137.47 Million USD | -0.85% |
| 2008 Q3 | 138.14 Million USD | -0.62% |
| 2008 Q4 | 137.47 Million USD | -0.48% |
| 2008 Q2 | 138.99 Million USD | 2.2% |
| 2008 Q1 | 136 Million USD | -1.91% |
| 2007 Q3 | 129.29 Million USD | -9.61% |
| 2007 Q4 | 138.65 Million USD | 7.24% |
| 2007 Q2 | 143.04 Million USD | 3.22% |
| 2007 Q1 | 138.58 Million USD | 3.52% |
| 2007 FY | 138.65 Million USD | 3.57% |
| 2006 FY | 133.87 Million USD | 19.58% |
| 2006 Q2 | 109.82 Million USD | -6.28% |
| 2006 Q4 | 133.87 Million USD | 12.91% |
| 2006 Q1 | 117.18 Million USD | 4.67% |
| 2006 Q3 | 118.57 Million USD | 7.96% |
| 2005 Q2 | 89.84 Million USD | 7.45% |
| 2005 Q4 | 111.95 Million USD | 13.91% |
| 2005 FY | 111.95 Million USD | 38.99% |
| 2005 Q1 | 83.61 Million USD | 3.81% |
| 2005 Q3 | 98.28 Million USD | 9.39% |
| 2004 Q2 | 73.01 Million USD | 190.23% |
| 2004 Q1 | 25.15 Million USD | 3.97% |
| 2004 Q3 | 76.17 Million USD | 4.33% |
| 2004 Q4 | 80.54 Million USD | 5.74% |
| 2004 FY | 80.54 Million USD | 232.87% |
| 2003 Q4 | 24.19 Million USD | 0.0% |
| 2003 FY | 24.19 Million USD | 56.87% |
| 2002 FY | 15.42 Million USD | 23.66% |
| 2001 FY | 12.47 Million USD | 77.25% |
| 2000 FY | 7.03 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -1004.033% |
| BrainsWay Ltd. | 62.97 Million USD | -449.913% |
| Cerus Corporation | 197.74 Million USD | -75.117% |
| Envoy Medical, Inc. | 7.64 Million USD | -4432.605% |
| electroCore, Inc. | 16.38 Million USD | -2013.206% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -4401.963% |
| IceCure Medical Ltd | 16.41 Million USD | -2010.244% |
| Inogen, Inc. | 326.19 Million USD | -6.161% |
| OrthoPediatrics Corp. | 449.58 Million USD | 22.976% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -1169.861% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1988.732% |
| MaxCyte, Inc. | 268.27 Million USD | -29.081% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -4176.616% |
| Nexalin Technology, Inc. | 3.63 Million USD | -9434.664% |
| Orthofix Medical Inc. | 925.31 Million USD | 62.576% |
| PAVmed Inc | 33.11 Million USD | -945.596% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -141.399% |
| RxSight, Inc. | 182.55 Million USD | -89.697% |
| Sight Sciences, Inc. | 166.65 Million USD | -107.794% |
| SI-BONE, Inc. | 230.42 Million USD | -50.284% |
| TELA Bio, Inc. | 78.04 Million USD | -343.69% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -37.468% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -3127.316% |
| Acutus Medical, Inc. | 53.96 Million USD | -541.755% |
| Talis Biomedical Corporation | 98.34 Million USD | -252.136% |
| Spectral AI, Inc. | 10.69 Million USD | -3138.786% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -58.378% |
| CVRx, Inc. | 115.22 Million USD | -200.524% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -490.326% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -11015.983% |
| Bioventus Inc. | 810.91 Million USD | 57.296% |
| Venus Concept Inc. | 93.65 Million USD | -269.756% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -1246.126% |
| LivaNova PLC | 2.42 Billion USD | 85.747% |
| 908 Devices Inc. | 202.98 Million USD | -70.603% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 56.994% |
| Nemaura Medical Inc. | 14.56 Million USD | -2277.844% |
| NeuroPace, Inc. | 107.65 Million USD | -221.679% |
| LENSAR, Inc. | 69.58 Million USD | -397.652% |
| Apyx Medical Corporation | 79.24 Million USD | -337.015% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -724.188% |
| BioSig Technologies, Inc. | 1.79 Million USD | -19159.789% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -27.956% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -711.727% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 90.844% |
| Axonics, Inc. | 719.92 Million USD | 51.899% |
| Outset Medical, Inc. | 313.8 Million USD | -10.354% |
| IRIDEX Corporation | 34.43 Million USD | -905.608% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 14.436% |
| IRadimed Corporation | 92.15 Million USD | -275.766% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -6490.997% |
| INVO Bioscience, Inc. | 20.88 Million USD | -1557.864% |
| Telesis Bio, Inc. | 70.41 Million USD | -391.814% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -124.715% |
| Varex Imaging Corporation | 1.24 Billion USD | 72.288% |
| Quipt Home Medical Corp. | 247.4 Million USD | -39.968% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -3619.56% |
| Pulmonx Corporation | 178.95 Million USD | -93.512% |
| Dynatronics Corporation | 25.94 Million USD | -1234.94% |
| Modular Medical, Inc. | 13.8 Million USD | -2408.083% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -3128.219% |
| Semler Scientific, Inc. | 78.06 Million USD | -343.593% |
| InMode Ltd. | 863.28 Million USD | 59.887% |
| Bruker Corporation | 4.24 Billion USD | 91.852% |
| Cytosorbents Corporation | 53.26 Million USD | -550.182% |
| DexCom, Inc. | 6.26 Billion USD | 94.472% |
| Align Technology, Inc. | 6.08 Billion USD | 94.308% |
| Viveve Medical, Inc. | 25.91 Million USD | -1236.36% |
| ZimVie Inc. | 1.2 Billion USD | 71.27% |
| Movano Inc. | 9.42 Million USD | -3575.735% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 30.417% |
| Nexalin Technology, Inc. | 3.63 Million USD | -9434.664% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -490.326% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 63.65% |
| Profound Medical Corp. | 43.68 Million USD | -692.676% |
| Insulet Corporation | 2.58 Billion USD | 86.62% |
| enVVeno Medical Corporation | 48.63 Million USD | -612.02% |
| Surmodics, Inc. | 185.73 Million USD | -86.446% |
| iCAD, Inc. | 41.41 Million USD | -736.088% |
| Nuwellis, Inc. | 9.77 Million USD | -3444.432% |
| Biotricity, Inc. | 5.94 Million USD | -5727.24% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 20.052% |
| Aethlon Medical, Inc. | 8.24 Million USD | -4099.512% |
| InspireMD, Inc. | 47.64 Million USD | -626.845% |
| PAVmed Inc. | 33.11 Million USD | -945.596% |
| BIOLASE, Inc. | 35.1 Million USD | -886.556% |
| Beyond Air, Inc. | 56.96 Million USD | -507.944% |
| FONAR Corporation | 214.24 Million USD | -61.632% |
| AxoGen, Inc. | 196.82 Million USD | -75.937% |
| Vivani Medical, Inc. | 45.79 Million USD | -656.143% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -23.043% |
| Inari Medical, Inc. | 674.23 Million USD | 48.639% |
| UFP Technologies, Inc. | 404.13 Million USD | 14.313% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -1379.967% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -3543.974% |
| Tenon Medical, Inc. | 6.34 Million USD | -5357.699% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -3581.205% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -234.104% |
| AdaptHealth Corp. | 4.61 Billion USD | 92.504% |
| Sintx Technologies, Inc. | 15.36 Million USD | -2153.765% |
| NanoVibronix, Inc. | 6.67 Million USD | -5088.657% |
| Quanterix Corporation | 425.01 Million USD | 18.522% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -3619.56% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -544.538% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 80.167% |
| TransMedics Group, Inc. | 706.04 Million USD | 50.954% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -447.998% |
| NeuroMetrix, Inc. | 21.42 Million USD | -1516.336% |
| Hyperfine, Inc. | 94.19 Million USD | -267.616% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -28.905% |
| Biomerica, Inc. | 9.25 Million USD | -3642.068% |
| Bone Biologics Corporation | 3.73 Million USD | -9164.659% |
| AVITA Medical, Inc. | 144.33 Million USD | -139.913% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -7012.844% |
| Silk Road Medical, Inc | 265.3 Million USD | -30.524% |